The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu

British Journal of Ophthalmology

Volumn 91, Issue 4, 2007, Pages 415-419

  Smith, Tasanee S T ^a   Szetu, John ^d   Bourne, Rupert R A ^b,c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b HINCHINGBROOKE HOSPITAL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Fred Hollows Foundation New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTHROPOMETRY; ARTICLE; BLINDNESS; BODY MASS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RETINOPATHY; RISK FACTOR; VANUATU; VISUAL IMPAIRMENT;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VANUATU; VISION DISORDERS; VISUAL ACUITY;

EID: 34247194075     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.104174     Document Type: Article

References (36)

1. Keeffe JE, Konyama K, Taylor HR. Vision impairment in the Pacific region. Br J Ophthalmol 2002;86:605-10.
2. Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 2000;6:43-52.
3. Collins VR, Dowse GK, Toelupe PM, et al. Increasing prevalence of NIDDM in the Pacific island population of Western Samoa over a 13-year period. Diabetes Care 1994;17:288-96.
4. Lako JV. Dietary trend and diabetes: its association among indigenous Fijians 1952 to 1994. Asia Pac J Clin Nutr 2001;10:183-7.
5. Papoz L, Barny S, Simon D, The CALDIA Study Group. Prevalence of diabetes mellitus in New Caledonia: ethinic and urban-rural differences. Am J Epidemiol 1996;143:1018-24.
6. Foliaki S, Pearce N. Prevention and control of diabetes in Pacific people. BMJ 2003;327:437-9.
7. WHO technical report series 916. Diet, nutrition and the prevention of chronic diseases:report of a joint WHO/FAO expert consultation. Geneva: WHO, 2002.
8. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994;37:278-85.
9. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
10. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-15.
11. Jarrett RJ. Duration of non-insulin-dependent diabetes and development of retinopathy: analysis of possible risk factors. Diabet Med 1986;3:261-3.
12. Adler AI, Stratton IM, Neil AW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Bmj 2000;321:412-19.
13. Ferris FL. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1.
14. Brandle M, Zhou H, Smith BRK, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26:2300-4.
15. Brooks B, Chong R, Ho I, et al. Diabetic retinopathy and nephropathy in Fiji: comparison with data from an Australian diabetes centre. Aust N Z J Ophthalmol 1999;27:9-13.
16. Collins VR, Dowse GK, Plehwe W, et al. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes Care 1995;18:1140-9.
17. Heriot WJ, Crock GW, Taylor R, et al. Ophthalmic findings among one thousand inhabitants of Rarotonga, Cook Islands. Aust J Ophthalmol 1983;11:81-94.
18. King H, Balkau B, Zimmet P, et al. Diabetic retinopathy in Nauruans. Am J Epidemiol 1983;117:659-67.
19. Newland HS, Harris MF, Walland M, et al. Epidemiology of blindness and visual impairment in Vanuatu. Bull World Health Organ 1992;70:369-72.
20. Taylor R, Jalaludin B, Levy S, et al. Prevalence of diabetes, hypertension and obesity at different levels of urbanisation in Vanuatu. Med J Aust 1991;155:86-90.
21. World Health Organization Regional Office for the Western Pacific. Vanuatu: Demographics, Gender and Poverty. http://www.wpro.who.int/countries/ 05van/2005 (accessed 23 January 2007).
22. United Nations Human Settlements Programme. Vanuatu urban population growth rate (%) and population aged 0-14 years (%). http:// www.unhabitat.org/habrdd/conditions/Melanesia/Vanuatu.htm, 2006.
23. Vanuatu statistics office. Population Summary (1999 Population Census). http:// www.vanuatustatistics.gov.vu/About%20VNSO/Data/Social/ Population.htm, 2006 (accessed 23 January 2007).
24. Guidelines Subcommittee of the World Health Organisation- International Society of Hypertension (WHO-ISH) Mild Hypertension Liason Committee. 1999 World Health Organisation-International Socity of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
25. World Health Organisation Technical Report Series 518. The prevention of blindness:report of a WHO Study Group. Geneva: WHO, 1973:1-18.
26. Mehra V, Minassian DC. A rapid method of grading cataract in epidemiological studies and eye surveys. Br J Ophthalmol 1988;72:801-3.
27. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study. BMJ 1995;311:1131-5.
28. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol 2004:920-4.
29. Nguyen HT, Luzio SD, Dolben J, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications 1996;10:211-9.
30. Rema M, Ponnaiya M, Mohan V. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in Southern India. Diabetes Res Clin Pract 1996;34:29-36.
31. World Health Organisation. Diabetes Programme: prevalence of diabetes in the WHO Western Pacific Region. http://www.who.int/diabetes/facts/ world_figures/en/index6.html2006 (accessed 23 January 2007)..
32. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes; Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1053.
33. Colagiuri S, Muimutheata S, Colagiuri R, et al. The prevalence of diabetes in the Kingdom of Tonga. Diabetes Care 2002;25:1378-83.
34. Simmons D, Williams DRR, Powell MJ. The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Q J Med 1991;81:1021-30.
35. Thomason MJ, Colhoun HM, Livingstone SJ, et al. Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. Diabet Med 2004;21:901-5.
36. World Health Organization. Epidemiological Fact Sheets on HIV/AIDS and sexually transmitted infections. http://www.who.int/GlobalAtlas/ PredefinedReports/EFS2004/EFS_PDFs/EFS2004_VU.pdf.